CMS Proposes 340B Drug Payment Cut That Would Shift Revenue from Safety-Net to For-Profit Hospitals

CMS's proposed Medicare reimbursement changes for 340B drugs would reduce safety-net hospital revenues while increasing for-profit hospital revenues, according to KFF analysis. CMS has proposed cutting Medicare reimbursement for drugs purchased through the 340B Drug Pricing Program while...